The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia
- 1 November 1996
- Vol. 48 (5) , 668-675
- https://doi.org/10.1016/s0090-4295(96)00249-x
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Urodynamic and Clinical Effects of Terazosin Therapy in Patients with Symptomatic Benign Prostatic HyperplasiaJournal of Urology, 1996
- The Correlation of Multichannel Urodynamic Pressure-Flow Studies and American Urological Association Symptom Index in the Evaluation of Benign Prostatic HyperplasiaJournal of Urology, 1995
- Variability of Pressure-Flow Analysis Parameters in Repeated Cystometry in Patients with Benign Prostatic HyperplasiaJournal of Urology, 1995
- Correlation of American Urological Association Symptom Index With Obstructive and Nonobstructive ProstatismJournal of Urology, 1995
- Benign Prostatic Hyperplasia — Medical and Minimally Invasive Treatment OptionsNew England Journal of Medicine, 1995
- A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstructionBritish Journal of Urology, 1994
- The Value of a New Symptom Score (DAN-PSS) in Diagnosing Uro-Dynamic Infravesical Obstruction in BPHScandinavian Journal of Urology and Nephrology, 1993
- A 12‐Week Placebo‐controlled Double‐blind Study of Prazosin in the Treatment of Prostatic Obstruction due to Benign Prostatic HyperplasiaBritish Journal of Urology, 1992
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- The Assessment of Prostatic Obstruction from Urodynamic Measurements and from Residual UrineBritish Journal of Urology, 1979